EVOEvotec SE
$1.57-61% 1Y
$1.57
$1.5352 weeks$4.15
The financials
Evotec SE by the numbers
For the full year FY2024, revenue was €797M (+2.0% year on year) and net income −€196M.
Drug Manufacturers, Specialty & Generic
Ranks #24 of 41 by RyuScore
For the full year FY2024, revenue was €797M (+2.0% year on year) and net income −€196M.
Ranks #24 of 41 by RyuScore